Clinicopathological variables such as tumor size, lymph node metastasis, histological grade, ER and PR expression, and HER2 status (also known as ERBB2), are prognostic and thereby drive decision making for breast cancer treatment (8). The gene discussed is PGR; the disease is breast cancer.